Teladoc Health Inc (TDOC)
9.05
-0.16
(-1.74%)
USD |
NYSE |
Nov 18, 16:00
9.03
-0.02
(-0.22%)
Pre-Market: 07:25
Teladoc Health Enterprise Value: 1.856B for Nov. 18, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 18, 2024 | 1.856B |
| November 15, 2024 | 1.883B |
| November 14, 2024 | 1.840B |
| November 13, 2024 | 1.945B |
| November 12, 2024 | 1.967B |
| November 11, 2024 | 1.986B |
| November 08, 2024 | 1.887B |
| November 07, 2024 | 1.935B |
| November 06, 2024 | 1.923B |
| November 05, 2024 | 1.873B |
| November 04, 2024 | 1.825B |
| November 01, 2024 | 1.883B |
| October 31, 2024 | 1.847B |
| October 30, 2024 | 1.823B |
| October 29, 2024 | 1.833B |
| October 28, 2024 | 1.878B |
| October 25, 2024 | 1.773B |
| October 24, 2024 | 1.778B |
| October 23, 2024 | 1.790B |
| October 22, 2024 | 1.847B |
| October 21, 2024 | 1.896B |
| October 18, 2024 | 1.989B |
| October 17, 2024 | 1.933B |
| October 16, 2024 | 1.979B |
| October 15, 2024 | 1.933B |
| Date | Value |
|---|---|
| October 14, 2024 | 1.845B |
| October 11, 2024 | 1.879B |
| October 10, 2024 | 1.929B |
| October 09, 2024 | 1.883B |
| October 08, 2024 | 1.795B |
| October 07, 2024 | 1.783B |
| October 04, 2024 | 1.852B |
| October 03, 2024 | 1.790B |
| October 02, 2024 | 1.798B |
| October 01, 2024 | 1.821B |
| September 30, 2024 | 1.876B |
| September 27, 2024 | 1.827B |
| September 26, 2024 | 1.818B |
| September 25, 2024 | 1.828B |
| September 24, 2024 | 1.888B |
| September 23, 2024 | 1.862B |
| September 20, 2024 | 1.876B |
| September 19, 2024 | 1.950B |
| September 18, 2024 | 1.934B |
| September 17, 2024 | 1.938B |
| September 16, 2024 | 1.775B |
| September 13, 2024 | 1.763B |
| September 12, 2024 | 1.683B |
| September 11, 2024 | 1.628B |
| September 10, 2024 | 1.619B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
1.541B
Minimum
Aug 14 2024
44.90B
Maximum
Feb 08 2021
11.38B
Average
6.179B
Median
Sep 12 2022
Enterprise Value Benchmarks
| American Shared Hospital Services | 33.14M |
| Astrana Health Inc | 1.740B |
| Cryo-Cell International Inc | 74.87M |
| P3 Health Partners Inc | 248.45M |
| Biote Corp | 275.75M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -33.28M |
| Revenue (Quarterly) | 640.51M |
| Total Expenses (Quarterly) | 680.87M |
| EPS Diluted (Quarterly) | -0.19 |
| Gross Profit Margin (Quarterly) | 71.94% |
| Profit Margin (Quarterly) | -5.20% |
| Earnings Yield | -63.76% |
| Normalized Earnings Yield | -22.15 |